drugset / Trial / NCT06705569

A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy Adults

NCT06705569

Phase 1 Completed 22 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this clinical trial is to compare the amount of tafamidis in the blood of healthy adult participants after taking two different forms of tafamidis by mouth.

Timeline

Start
2024-12-20
Primary completion
2025-04-04
Completion
2025-04-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Tafamidis Unknown 61 mg Oral

Indications

No indication recorded.